Merck’s Udit Batra Receives ‘CEO of the Year’ Award

05-Oct-2016 - Germany

Merck announced that the CEO of its life science business, Udit Batra, was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.

The company also won two CPhI Pharma Awards—one for excellence in excipients and formulation development and another for regulatory procedures and compliance. CPhI announced the awards at the organization’s annual awards gala on Oct. 4 in Barcelona, Spain.

“As advances in drug discovery yield more complex therapies, drug development and manufacturing must innovate at even a faster pace,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “At Merck, we will continue to empower researchers and scientists with solutions that improve drug development quality and efficiency, helping them solve their toughest problems. On behalf of Merck, I am honored to receive this award.”

Recognition showcases some of the company’s world-class technologies and solutions for researchers, drug developers and clinical lab customers working to treat disease.

The CPhI Pharma Awards acknowledged Merck’s groundbreaking innovations in technology, formulation, regulatory procedures and product development. Merck received the following technology awards:

Parteck^®SRP 80 won for “Excipients and Formulation Development.” Parteck^® SRP 80 is a functional direct compressable excipient designed for oral sustained-release formulations. It is fully synthetic for batch-to-batch and performance consistency and enhances the bioavailability of actives.
The Emprove^®program won for “Regulatory Procedures and Compliance.” The program provides documentation and regulatory information on materials used in the manufacture of drug products. This information enhances transparency, facilitates manufacturers’ risk assessment workflows and su

https://www.bionity.com/en/news/159987/mercks-udit-batra-receives-ceo-of-the-year-award.html